Legal & General Group Plc Reduces Stake in Cencora, Inc. $COR

Legal & General Group Plc cut its stake in Cencora, Inc. (NYSE:COR) by 6.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,350,258 shares of the company’s stock after selling 91,497 shares during the quarter. Legal & General Group Plc owned approximately 0.70% of Cencora worth $456,050,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Cencora by 13.0% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,270 shares of the company’s stock valued at $15,086,000 after acquiring an additional 5,543 shares during the period. AustralianSuper Pty Ltd acquired a new position in Cencora in the third quarter valued at approximately $26,191,000. Mediolanum International Funds Ltd lifted its holdings in Cencora by 133.0% in the third quarter. Mediolanum International Funds Ltd now owns 56,293 shares of the company’s stock valued at $17,342,000 after acquiring an additional 32,138 shares during the period. Chilton Investment Co. Inc. acquired a new position in Cencora in the third quarter valued at approximately $459,000. Finally, Advisors Asset Management Inc. lifted its holdings in Cencora by 40.3% in the third quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock valued at $5,407,000 after acquiring an additional 4,973 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

Cencora Trading Up 0.0%

Shares of COR stock opened at $275.01 on Tuesday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market cap of $53.51 billion, a price-to-earnings ratio of 21.09, a PEG ratio of 1.27 and a beta of 0.64. The stock has a 50 day simple moving average of $304.15 and a 200-day simple moving average of $336.24. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the company earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities research analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.

Cencora declared that its board has approved a stock buyback plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

COR has been the subject of a number of analyst reports. Morgan Stanley set a $342.00 price target on Cencora in a report on Friday, May 8th. Wells Fargo & Company decreased their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. JPMorgan Chase & Co. boosted their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Leerink Partners reissued an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Evercore set a $360.00 target price on Cencora in a research note on Wednesday, April 8th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.